Capital Bank & Trust CO Ultragenyx Pharmaceutical Inc. Transaction History

Capital Bank & Trust CO

$0
Q3 2022

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$77.92 - $102.4 $4.7 Million - $6.18 Million	-60,332 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$92.19 - $115.71 $921 - $1,157	10 Added 0.02%	60,332 $5.75 Million
Q1 2021 May 14, 2021	SELL	$106.9 - $167.73 $33,673 - $52,834	-315 Reduced 0.52%	60,322 $6.87 Million
Q4 2020 Feb 16, 2021	SELL	$84.4 - $177.39 $71,740 - $150,781	-850 Reduced 1.38%	60,637 $8.39 Million
Q3 2020 Nov 13, 2020	BUY	$72.98 - $90.0 $31,527 - $38,880	432 Added 0.71%	61,487 $5.05 Million
Q2 2020 Aug 14, 2020	BUY	$46.91 - $78.22 $110,285 - $183,895	2,351 Added 4.0%	61,055 $4.78 Million
Q1 2020 May 15, 2020	BUY	$33.8 - $62.9 $3,244 - $6,038	96 Added 0.16%	58,704 $2.61 Million
Q4 2019 Feb 18, 2020	SELL	$36.08 - $45.83 $2.53 Million - $3.21 Million	-70,092 Reduced 54.46%	58,608 $2.5 Million
Q3 2019 Nov 14, 2019	SELL	$42.5 - $63.11 $1.48 Million - $2.2 Million	-34,892 Reduced 21.33%	128,700 $5.51 Million
Q2 2019 Aug 14, 2019	BUY	$54.93 - $74.36 $292,557 - $396,041	5,326 Added 3.37%	163,592 $10.3 Million
Q1 2019 May 15, 2019	BUY	$39.87 - $69.36 $1.51 Million - $2.63 Million	37,959 Added 31.55%	158,266 $10.9 Million
Q4 2018 Feb 14, 2019	BUY	$38.89 - $77.3 $52,423 - $104,200	1,348 Added 1.13%	120,307 $5.23 Million
Q3 2018 Nov 14, 2018	SELL	$71.81 - $90.15 $85,166 - $106,917	-1,186 Reduced 0.99%	118,959 $9.08 Million
Q2 2018 Aug 14, 2018	BUY	$48.54 - $85.31 $34,948 - $61,423	720 Added 0.6%	120,145 $9.24 Million
Q1 2018 May 15, 2018	BUY	$44.33 - $58.52 $677,539 - $894,419	15,284 Added 14.68%	119,425 $6.09 Million
Q4 2017 Feb 14, 2018	SELL	$43.54 - $57.32 $752,066 - $990,088	-17,273 Reduced 14.23%	104,141 $4.83 Million
Q3 2017 Nov 14, 2017	SELL	$49.79 - $66.32 $27,235 - $36,277	-547 Reduced 0.45%	121,414 $6.47 Million
Q2 2017 Aug 14, 2017	BUY	N/A	121,961	121,961 $7.58 Million

Others Institutions Holding RARE

# of Institutions

326

Shares Held

85.7M

Call Options Held

520K

Put Options Held

406K

Vanguard Group Inc Valley Forge, PA

9.95M
Shares

$447 Million
0.01% of portfolio
Black Rock Inc. New York, NY

5.6M
Shares

$252 Million
0.01% of portfolio
Sands Capital Management, LLC Arlington, VA

5.12M
Shares

$230 Million
0.91% of portfolio
Wellington Management Group LLP Boston, MA

4.17M
Shares

$187 Million
0.04% of portfolio
Price T Rowe Associates Inc Baltimore, MD

3.07M
Shares

$138 Million
0.02% of portfolio

View Full List

About Ultragenyx Pharmaceutical Inc.

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.15B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

More about RARE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Bank & Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Capital Bank & Trust CO with notifications on news.

Account